Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.82 |
| ▸ | EYA2 | O00167 | 1/20 | 0.82 |
| ▸ | APP | P05067 | 1/20 | 0.82 |
| ▸ | ACE | P12821 | 1/20 | 0.82 |
| ▸ | BLM | P54132 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.78 |
| ▸ | DRD1 | P21728 | 1/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.78 |
| ▸ | DRD3 | P35462 | 1/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.78 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL68140 | 1.00 | TDP1 (0.82) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6684859 | 0.92 | TDP1 (0.70) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1373 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8607480 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16714076 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL3035039 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8624198 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL15136 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16570043 | 0.90 | TDP1 (0.67) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL10542859 | 0.88 | TDP1 (0.93) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240181223-A1 | NEUROSURGICAL APPARATUS AND METHODS | RENISHAW PLC (GB) | 2024-06-06 | — | — | US | disclosed |
| EP-2877108-B1 | NEUROSURGICAL APPARATUS | RENISHAW PLC (GB) | 2023-06-07 | — | — | EP | disclosed |
| EP-3830182-A1 | HIGH-MOLECULAR-WEIGHT FUCANS FOR TREATING FIBROUS ADHESIONS AND OTHER DISEASES AND CONDITIONS | Arc Medical Devices, Inc. (CA) | 2021-06-09 | — | — | EP | disclosed |
| US-20200324089-A1 | NEUROSURGICAL APPARATUS AND METHODS | RENISHAW PLC (GB) | 2020-10-15 | — | — | US | disclosed |
| US-10751513-B2 | Neurosurgical apparatus and methods | RENISHAW PLC (GB) | 2020-08-25 | — | — | US | disclosed |
| WO-2020019078-A1 | HIGH-MOLECULAR-WEIGHT FUCANS FOR TREATING FIBROUS ADHESIONS AND OTHER DISEASES AND CONDITIONS | ARC MEDICAL DEVICES INC. (CA) | 2020-01-30 | — | — | WO | disclosed |
| CN-105377302-B | Polymer micelle medical composition | 那野伽利阿株式会社 | 2018-05-11 | — | — | CN | disclosed |
| CN-101952461-B | For detecting composition, method and the kit of ribonucleic acid | 应用生物系统有限公司 | 2017-12-05 | — | — | CN | disclosed |
| US-20160114058-A1 | POLYMER MICELLE PHARMACEUTICAL COMPOSITION | NANOCARRIER CO., LTD. (JP) | 2016-04-28 | — | — | US | disclosed |
| EP-2997979-A1 | POLYMERIC MICELLE PHARMACEUTICAL COMPOSITION | NanoCarrier Co., Ltd. (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-0794953-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1997-09-17 | — | — | EP | disclosed |
| EP-0737085-A1 | VACCINE FOR $i(BRANHAMELLA CATARRHALIS) | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AT BUFFALO (US) | 1996-10-16 | — | — | EP | disclosed |
| WO-1996016960-A1 | QUINAZOLINE DERIVATIVES | ZENECA LIMITED (GB) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995009025-A1 | VACCINE FOR $i(BRANHAMELLA CATARRHALIS) | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1995-04-06 | — | — | WO | disclosed |
| US-5219739-A | Wound healing agents | SCIOS NOVA INC. (US) | 1993-06-15 | — | — | US | disclosed |
| US-5194596-A | Wound healing agents | CALIFORNIA BIOTECHNOLOGY INC. (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0514501-A1 | DETECTION OF POINT MUTATIONS IN GENES ENCODING GTP BINDING PROTEINS | F. HOFFMANN-LA ROCHE AG (CH) | 1992-11-25 | — | — | EP | disclosed |
| WO-1991012343-A2 | DETECTION OF POINT MUTATIONS IN GENES ENCODING GTP BINDING PROTEINS | F. HOFFMANN-LA ROCHE AG (CH) | 1991-08-22 | — | — | WO | disclosed |
| US-4159895-A | MEAN CORPUSCULAR VOLUME AND MEAN CORPUSCULAR HEMOGLOBIN | COULTER ELECTRONICS, INC. (US) | 1979-07-03 | — | — | US | disclosed |
| US-3955928-A | Pregnancy test | YEE HUGH | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160114058-A1 | POLYMER MICELLE PHARMACEUTICAL COMPOSITION | SSR4, ABCC1, PMM2 | TDP1 3436/4885EYA2 4307/4885APP 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.